Business Context and Reporting Period
This Form 8-K Current Report covers events occurring on February 12, 2020, for Duos Technologies Group, Inc. (DUOT), a Florida corporation. The filing primarily details the execution of a firm commitment underwritten public offering of common stock and the commencement of trading on the Nasdaq Capital Market.
Key Financial Metrics and Transaction Details
- Offering Size: 1,350,000 shares of Common Stock sold at a public offering price of $6.00 per share.
- Over-Allotment Option: Underwriters granted an option to purchase up to an additional 202,500 shares within 45 days.
- Net Proceeds: Approximately $6,999,268 after deducting underwriting discounts, fees, and estimated expenses.
- Underwriter Warrants: Issued warrants to purchase 67,500 shares at an exercise price of $9.00 per share, exercisable from August 10, 2020, through February 12, 2023.
- Trading Status: Common Stock began trading under the symbol "DUOT" on February 13, 2020.
Material Changes and Use of Proceeds
The filing represents a material change in the company's capital structure and liquidity position due to the equity raise. The Company anticipates utilizing the net proceeds as follows:
- $4,000,000: Capital expenditures and working capital.
- $2,400,000: Research and development for new products, improvements, hiring key personnel, and material costs.
- $500,000: Upgrading sales and marketing capabilities, including professional relations, advertising, software, and staffing.
- Remainder: General corporate purposes and potential acquisitions (though none are currently contemplated).
Guidance, Risks, and Contingencies
- Lock-Up Agreements: The Company, its directors, and executive officers agreed not to sell or transfer securities for 90 days following the Underwriting Agreement date, subject to customary exceptions.
- Acquisition Contingency: While proceeds may be used for acquisitions, the filing explicitly states that no such acquisitions are currently contemplated.
- Warrant Exercise Risk: The underwriter warrants have a higher exercise price ($9.00) than the offering price ($6.00), creating a specific dilution scenario if the stock price appreciates significantly.
Investor Verification Checklist
- Verify the final closing date of the offering (February 18, 2020) and whether the over-allotment option was exercised.
- Confirm the actual net proceeds received versus the estimated $6,999,268.
- Review the full text of the Underwriting Agreement (Exhibit 10.1) for specific indemnification obligations and termination provisions.
- Monitor the 90-day lock-up expiration date for potential selling pressure from insiders.
- Track the allocation of funds to ensure alignment with the stated use of proceeds (R&D, CapEx, Marketing).